0001804846-20-000001.txt : 20200304 0001804846-20-000001.hdr.sgml : 20200304 20200304134308 ACCESSION NUMBER: 0001804846-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200304 DATE AS OF CHANGE: 20200304 EFFECTIVENESS DATE: 20200304 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Woolsey Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001804846 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-361938 FILM NUMBER: 20686513 BUSINESS ADDRESS: STREET 1: 233 BROADWAY, SUITE 1750 CITY: NEW YORK STATE: NY ZIP: 10279 BUSINESS PHONE: 212-586-2226 MAIL ADDRESS: STREET 1: 233 BROADWAY, SUITE 1750 CITY: NEW YORK STATE: NY ZIP: 10279 D 1 primary_doc.xml X0708 D LIVE 0001804846 Woolsey Pharmaceuticals, Inc. 233 BROADWAY, SUITE 1750 NEW YORK NY NEW YORK 10279 212-586-2226 DELAWARE None None Corporation true 2019 DAVID M. GELIEBTER 233 BROADWAY, SUITE 1750 NEW YORK NY NEW YORK 10279 Director SVEN M. JACOBSON 233 BROADWAY, SUITE 1750 NEW YORK NY NEW YORK 10279 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false 2020-02-18 false true false 0 7791001 7791001 0 false 51 0 0 0 false Woolsey Pharmaceuticals, Inc. SVEN M. JACOBSON SVEN M. JACOBSON CHIEF EXECUTIVE OFFICER 2020-03-03